Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data

Giorgio Walter Canonica; Philippe Devillier; Thomas Casale; Pascal Demoly; Catherine Bos; Efstrathios Karagiannis; Giovanni Passalacqua; Ulrich Wahn; Laurent Mascarell

doi:10.1080/1744666X.2019.1649597

Back

Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data

Journal article

Open access

Peer reviewed

Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data

Giorgio Walter Canonica, Philippe Devillier, Thomas Casale, Pascal Demoly, Catherine Bos, Efstrathios Karagiannis, Giovanni Passalacqua, Ulrich Wahn and Laurent Mascarell

Expert Review of Clinical Immunology, Vol.15(9), pp.921-928

02/09/2019

DOI: https://doi.org/10.1080/1744666X.2019.1649597

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1080/1744666X.2019.1649597View

Published (Version of record) Open

Metrics

1 Record Views

Details

Title: Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data
Creators - without role: Giorgio Walter Canonica - Humanitas University
Philippe Devillier - Université de Versailles Saint-Quentin-en-Yvelines
Thomas Casale - University of South Florida
Pascal Demoly - Inserm
Catherine Bos - Stallergenes Greer
Efstrathios Karagiannis - Stallergenes Greer
Giovanni Passalacqua - Ospedale Policlinico San Martino
Ulrich Wahn - Charité - Universitätsmedizin Berlin
Laurent Mascarell - Stallergenes Greer
Publication Details: Expert Review of Clinical Immunology, Vol.15(9), pp.921-928
Identifiers: 9941024309311
Academic Unit: Institut Desbrest d Epidemiologie et de Sante Publique - IDESP
Language: English
Resource Type: Journal article
Local Fields: hal-04265141